250 related articles for article (PubMed ID: 34502278)
21. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
[TBL] [Abstract][Full Text] [Related]
22. Current status and perspectives of patient-derived xenograft models in cancer research.
Lai Y; Wei X; Lin S; Qin L; Cheng L; Li P
J Hematol Oncol; 2017 May; 10(1):106. PubMed ID: 28499452
[TBL] [Abstract][Full Text] [Related]
23. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K
In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine.
Okada S; Vaeteewoottacharn K; Kariya R
Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256
[TBL] [Abstract][Full Text] [Related]
25. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
[TBL] [Abstract][Full Text] [Related]
26. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
[TBL] [Abstract][Full Text] [Related]
27. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract][Full Text] [Related]
28. Development of Patient-Derived Tumor Xenograft Models.
Annibali D; Leucci E; Hermans E; Amant F
Methods Mol Biol; 2019; 1862():217-225. PubMed ID: 30315470
[TBL] [Abstract][Full Text] [Related]
29. HER2 as a novel therapeutic target for cervical cancer.
Oh DY; Kim S; Choi YL; Cho YJ; Oh E; Choi JJ; Jung K; Song JY; Ahn SE; Kim BG; Bae DS; Park WY; Lee JW; Song S
Oncotarget; 2015 Nov; 6(34):36219-30. PubMed ID: 26435481
[TBL] [Abstract][Full Text] [Related]
30. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
31. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization.
Miyamoto S; Tanaka T; Hirosuna K; Nishie R; Ueda S; Hashida S; Terada S; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740635
[TBL] [Abstract][Full Text] [Related]
32. A novel immunodeficient rat model supports human lung cancer xenografts.
He D; Zhang J; Wu W; Yi N; He W; Lu P; Li B; Yang N; Wang D; Xue Z; Zhang P; Fan G; Zhu X
FASEB J; 2019 Jan; 33(1):140-150. PubMed ID: 29944447
[TBL] [Abstract][Full Text] [Related]
33. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
34. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
[TBL] [Abstract][Full Text] [Related]
36. Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies.
William D; Mullins CS; Schneider B; Orthmann A; Lamp N; Krohn M; Hoffmann A; Classen CF; Linnebacher M
J Transl Med; 2017 Feb; 15(1):27. PubMed ID: 28183348
[TBL] [Abstract][Full Text] [Related]
37. Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.
Kamili A; Gifford AJ; Li N; Mayoh C; Chow SO; Failes TW; Eden GL; Cadiz R; Xie J; Lukeis RE; Norris MD; Haber M; McCowage GB; Arndt GM; Trahair TN; Fletcher JI
Br J Cancer; 2020 Mar; 122(5):680-691. PubMed ID: 31919402
[TBL] [Abstract][Full Text] [Related]
38. PDXliver: a database of liver cancer patient derived xenograft mouse models.
He S; Hu B; Li C; Lin P; Tang WG; Sun YF; Feng FY; Guo W; Li J; Xu Y; Yao QL; Zhang X; Qiu SJ; Zhou J; Fan J; Li YX; Li H; Yang XR
BMC Cancer; 2018 May; 18(1):550. PubMed ID: 29743053
[TBL] [Abstract][Full Text] [Related]
39. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
[TBL] [Abstract][Full Text] [Related]
40. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.
Dong X; Guan J; English JC; Flint J; Yee J; Evans K; Murray N; Macaulay C; Ng RT; Gout PW; Lam WL; Laskin J; Ling V; Lam S; Wang Y
Clin Cancer Res; 2010 Mar; 16(5):1442-51. PubMed ID: 20179238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
